Search results
Results from the WOW.Com Content Network
Its current director is Dr. Richard Woychik, who is also concurrently the director of the National Toxicology Program. [12] The deputy director is Dr. Trevor Archer. The director of the NIEHS reports to the director of the NIH, of which the NIEHS is a member agency. [13] NIEHS is composed of:
The National Toxicology Program (NTP) is an inter-agency program run by the United States Department of Health and Human Services to coordinate, evaluate, and report on toxicology within public agencies.
The NIH Office of Science Policy works on a wide range of issues including biosafety, [2] biosecurity, [3] genetic testing, genomic data sharing, [4] human subjects protections, [5] the organization and management of the NIH, and the outputs and value of NIH-funded research. This is accomplished through a wide range of analyses and reports ...
Therapeutic drug monitoring (TDM) is a branch of clinical chemistry and clinical pharmacology that specializes in the measurement of medication levels in blood. Its main focus is on drugs with a narrow therapeutic range , i.e. drugs that can easily be under- or overdosed. [ 1 ]
Prescription drug monitoring programs, or PDMPs, are an example of one initiative proposed to alleviate effects of the opioid crisis. [1] The programs are designed to restrict prescription drug abuse by limiting a patient's ability to obtain similar prescriptions from multiple providers (i.e. “doctor shopping”) and reducing diversion of controlled substances.
The post Former NIH Director: Ignoring 'Collateral Damage' Inflicted by COVID-19 Policies Was 'Really Unfortunate' appeared first on Reason.com. Show comments Advertisement
The mission of the NIH OTT is to improve public health through the management of inventions made by NIH and FDA scientists and the development of intellectual property policies for NIH's intramural and extramural research programs. In doing so, OTT serves a leading role in public sector biomedical technology transfer policy and practice.
They may also use prescription-drug monitoring programs (PDMPs) to track drug prescription and dispensing patterns in patients. [20] Patient-wise, some organizations have suggested ways to use prescription drugs properly. For example, the NIDA guideline recommends patients to: following the directions as explained on the label or by the pharmacist